3-吡啶甲醇

≥98%

CAS编号: 100-55-0
分子式: C₆H₇NO
分子量: 109.13
Beilstein号: 107851
EC号: 202-864-6
MDL号: MFCD00006407
PubChem编号: 7510

有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭

货号 (SKU)	包装规格	是否现货
P106580-5g	5g	现货
P106580-10g	10g	现货
P106580-25g	25g	现货
P106580-100g	100g	现货
P106580-500g	500g	现货

查看相关系列

N-杂环化合物 (14) 吡啶类 (1251) 吡啶类 C5-C6 (3) 无卤杂环砌块 (1206) 杂环砌块 (491)

Skip to the end of the images gallery

Skip to the beginning of the images gallery

基本描述

别名	烟醇 \| 3-(羟甲基)吡啶 \| 吡啶-3-甲醇 \| ω-羟基-3-皮考啉
英文别名	Roniacol \| Pyridine-3-carbinol \| pyridin-3-ylmethanol \| Pyridine-3-methanol \| Pyridylcarbinol \| 3-Pyridylcarbinol \| 3-Pyridinylmethanol \| Nicotinyl alcohol \| beta-Pyridylcarbinol \| 3-(Hydroxymethyl)pyridine \| Nicotinic alcohol \| 3-Pyridylmethanol
规格或纯度	≥98%
英文名称	3-Pyridinemethanol
储存温度	2-8°C储存,充氩
运输条件	冰袋运输
产品介绍	易溶于水，易溶于醚。3-吡啶甲醇是一种芳香族伯醇，是许多具有生物活性和工业重要性的化合物的关键成分。用途： 3-吡啶甲醇在催化量的氢溴酸存在下可发生好氧光氧化，从而形成烟酸。 3-Pyridinemethanol, an aromatic primary alcohol, is the key moiety of many bio-active and industrially important compounds. Application： 3-Pyridinemethanol can undergo aerobic photo-oxidation in the presence of catalytic amount of hydrobromic acid to form nicotinic acid.

AI解读

关联靶点（人）

RUNX1 Tbio Runt-related transcription factor 1/Core-binding factor subunit beta (7867 活性数据)

点击查看靶蛋白信息： RUNX1

活性类型	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

关联靶点（其它种属）

Hdac6 Histone deacetylase 6 (222 活性数据)

点击查看靶蛋白信息： Hdac6

活性类型	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Pseudomonas aeruginosa (123386 活性数据)

点击查看此靶标相关信息

活性类型	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Klebsiella pneumoniae (43867 活性数据)

点击查看此靶标相关信息

活性类型	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Staphylococcus aureus (210822 活性数据)

点击查看此靶标相关信息

活性类型	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Acinetobacter baumannii (41033 活性数据)

点击查看此靶标相关信息

活性类型	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Escherichia coli (133304 活性数据)

点击查看此靶标相关信息

活性类型	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Cryptococcus neoformans (21258 活性数据)

点击查看此靶标相关信息

活性类型	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Candida albicans (78123 活性数据)

点击查看此靶标相关信息

活性类型	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

Rattus norvegicus (775804 活性数据)

点击查看此靶标相关信息

活性类型	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

GCN5 Histone acetyltransferase GCN5 (89 活性数据)

点击查看靶蛋白信息： GCN5

活性类型	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

SARS-CoV-2 (38078 活性数据)

点击查看此靶标相关信息

活性类型	Relation	Activity value	Units	Action Type	Journal	PubMed Id	doi	Assay Aladdin ID

作用机制

作用机制	Action Type	target ID	Target Name	Target Type	Target Organism	Binding Site Name	参考文献

名称和识别符

EC号	202-864-6
分子类型	小分子
IUPAC Name	pyridin-3-ylmethanol
INCHI	InChI=1S/C6H7NO/c8-5-6-2-1-3-7-4-6/h1-4,8H,5H2
InChi Key	MVQVNTPHUGQQHK-UHFFFAOYSA-N
Canonical SMILES	C1=CC(=CN=C1)CO
Isomeric SMILES	C1=CC(=CN=C1)CO
WGK Germany	3
RTECS	UT4690000
PubChem CID	7510
分子量	109.13
Beilstein号	107851
Reaxy-Rn	107851

化学和物理性质

溶解性	Fully miscible in water.
密度	1.124
敏感性	易吸潮;对空气敏感
折光率	1.545
闪点(℉)	275 °F
闪点(℃)	110 °C
沸点	154 °C/28 mmHg
熔点	-8to-6°C
分子量	109.130 g/mol
XLogP3	0.000
氢键供体数Hydrogen Bond Donor Count	1
氢键受体数Hydrogen Bond Acceptor Count	2
可旋转键计数Rotatable Bond Count	1
精确质量Exact Mass	109.053 Da
单同位素质量Monoisotopic Mass	109.053 Da
拓扑极表面积Topological Polar Surface Area	33.100 Å²
重原子数Heavy Atom Count	8
形式电荷Formal Charge	0
复杂度Complexity	65.500
同位素原子数Isotope Atom Count	0
定义的原子立体中心计数Defined Atom Stereocenter Count	0
未定义的原子立体中心计数Undefined Atom Stereocenter Count	0
定义的键立体中心计数Defined Bond Stereocenter Count	0
未定义的键立体中心计数Undefined Bond Stereocenter Count	0
所有立体化学键的总数The total count of all stereochemical bonds	0
共价键合单元计数Covalently-Bonded Unit Count	1

安全和危险性（GHS）

象形图	GHS07
信号词	Warning
危险声明	H315: 引起皮肤刺激 H319: 引起严重眼睛刺激 H335: 可能引起呼吸道刺激
预防措施声明	P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P305+P351+P338: 如进入眼睛：用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出，取出隐形眼镜。继续冲洗。 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P302+P352: 如皮肤沾染：用水充分清洗。 P321: 特殊处理（请参阅此标签上的...）。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P264: 处理后要彻底洗手。 P271: 仅在室外或通风良好的地方使用。 P304+P340: 如误吸入：将人转移到空气新鲜处，保持呼吸舒适体位。 P403+P233: 存放在通风良好的地方。保持容器密闭。 P362+P364: 脱掉沾污的衣服，清洗后方可重新使用。 P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。 P337+P317: 如果眼睛刺激持续：寻求医疗帮助。 P332+P317: 如果出现皮肤刺激：请寻求医疗帮助。 P319: 如果你感到不适，请寻求医疗帮助。
WGK Germany	3
RTECS	UT4690000
Reaxy-Rn	107851
Merck Index	6527
个人防护装备	Eyeshields,full-face respirator (US),Gloves,multi-purpose combination respirator cartridge (US),type ABEK (EN14387) respirator filter

SDS英文版

技术规格说明书

Purity(GC)	98-100（%）
Density (25°C)	1.135-1.139
Refractive index n20/D	1.542-1.547
Appearance（P106580)	Colorless to Yellow Liquid
Proton NMR spectrum	Conforms to Structure

技术规格说明书

质检证书（CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):

输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！

找到23个结果

批号(Lot Number)	证书类型	日期	货号
A2112210	分析证书	24-10-15	P106580
A2112209	分析证书	24-10-15	P106580
H2430260	分析证书	24-07-31	P106580
E2520040	分析证书	24-07-31	P106580
H2430264	分析证书	24-07-31	P106580
G2402461	分析证书	24-05-27	P106580
G2402462	分析证书	24-05-27	P106580
D2416414	分析证书	24-04-07	P106580
D2416415	分析证书	24-04-07	P106580
D2416416	分析证书	24-03-16	P106580
B2421457	分析证书	24-01-27	P106580
B2421454	分析证书	24-01-27	P106580
B2421456	分析证书	24-01-27	P106580
B2421458	分析证书	24-01-27	P106580
K2315380	分析证书	23-11-07	P106580
K2315384	分析证书	23-11-07	P106580
K2315389	分析证书	23-11-07	P106580
K2315478	分析证书	23-11-07	P106580
L1919111	分析证书	23-10-20	P106580
H1905104	分析证书	23-05-08	P106580
J1825099	分析证书	22-09-09	P106580
F2225508	分析证书	22-06-07	P106580
F2225602	分析证书	22-06-07	P106580

显示更多⌵

可替换产品

参考文献

1. C P Felley,H Kleiber,G D van Melle,P Frascarolo,E Jéquier,J P Felber. (1992-03-01) Resistance to insulin mediated glucose disposal in obese subjects: respective effect of lipid metabolism and glycemia.. International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 16 ((3)): (185-191). [PMID:1317827]
2. H Kleiber,R Munger,D Jallut,L Tappy,C Felley,A Golay,P Frascarolo,E Jéquier,J P Felber. (1992-03-01) Interaction of lipid and carbohydrate metabolism after infusions of lipids or of lipid lowering agents: lack of a direct relationship between free fatty acid concentrations and glucose disposal.. Diabete & metabolisme, 18 ((2)): (84-90). [PMID:1511757]
3. M Sakamoto,S Yanagi,T Kamiya. (1987-09-15) Inhibitory effects of niacin and its analogues on induction of ornithine decarboxylase activity by diethylnitrosamine in rat liver.. Biochemical pharmacology, 36 ((18)): (3015-3019). [PMID:2888466]
4. C Keller,W Zoller,G Wolfram,N Zöllner. (1988-07-15) Unusual but reversible hepatic lesions following long-term treatment with pyridylcarbinol for familial hypercholesterolemia.. Klinische Wochenschrift, 66 ((14)): (647-650). [PMID:3062265]
5. T B Gelhard,J Arends. (1988-06-01) The effect of fluoride containing toothpastes on sound human enamel in vivo during 3 weeks.. Journal de biologie buccale, 16 ((2)): (95-99). [PMID:3170533]
6. J Manzanares,R Cantón,F Zaragoza. (1988-03-15) Effect of beta-pyridyl-carbinol on platelet aggregation.. Thrombosis research, 49 ((6)): (501-508). [PMID:3388307]
7. M Went. (1987-06-01) [Use of a caudal epidural sympathetic nerve block and a combination injection in chronic arterial circulatory disorders of the lower extremities].. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 42 ((11)): (313-316). [PMID:3660887]
8. P P Rop,F Grimaldi,C Oddoze,A Viala. (1993-02-26) Determination of nicotine and its main metabolites in urine by high-performance liquid chromatography.. Journal of chromatography, 612 ((2)): (302-309). [PMID:8468389]
9. D J Wise,C D Anderson,B M Anderson. (1997-08-01) Purification and kinetic characterization of Haemophilus parasuis malate dehydrogenase.. Archives of biochemistry and biophysics, 344 ((1)): (176-183). [PMID:9244395]
10. H Tomozawa,M Momonaga,T Uemura,H Yazawa. (1999-01-07) Influence of powder characteristics of bulk substance with pharmaceutical processing.. Drug development and industrial pharmacy, 24 ((9)): (857-861). [PMID:9876537]
11. D Cui,P J Harvison. (2000-11-21) Determination of the site of glucuronidation in an N-(3,5-dichlorophenyl)succinimide metabolite by electrospray ionization tandem mass spectrometry following derivatization to picolinyl esters.. Rapid communications in mass spectrometry : RCM, 14 ((21)): (1985-1990). [PMID:11085408]
12. Matteo de Rosa,Andrea Pennati,Vittorio Pandini,Enrico Monzani,Giuliana Zanetti,Alessandro Aliverti. (2007-07-20) Enzymatic oxidation of NADP+ to its 4-oxo derivative is a side-reaction displayed only by the adrenodoxin reductase type of ferredoxin-NADP+ reductases.. The FEBS journal, 274 ((15)): (3998-4007). [PMID:17635583]
13. Manisha Singla,Pavan Mathur. (2009-08-08) Oxidation of alcohols using a manganese (II) complex based on a pentakis benzimidazole amide ligand.. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 74 ((2)): (536-543). [PMID:19660981]
14. Francisco J Ramos-Lima,Victoria Moneo,Adoración G Quiroga,Amancio Carnero,Carmen Navarro-Ranninger. (2009-10-27) The role of p53 in the cellular toxicity by active trans-platinum complexes containing isopropylamine and hydroxymethylpyridine.. European journal of medicinal chemistry, 45 ((1)): (134-141). [PMID:19853978]
15. A Latif Abuhijleh,Juhienah Khalaf. (2010-07-08) Copper (II) complexes of the anti-inflammatory drug naproxen and 3-pyridylmethanol as auxiliary ligand. Characterization, superoxide dismutase and catecholase--mimetic activities.. European journal of medicinal chemistry, 45 ((9)): (3811-3817). [PMID:20605277]
16. Evelina Charidemou,Tom Ashmore,Xuefei Li,Ben D McNally,James A West,Sonia Liggi,Matthew Harvey,Elise Orford,Julian L Griffin. (2019-05-31) A randomized 3-way crossover study indicates that high-protein feeding induces de novo lipogenesis in healthy humans.. JCI insight, 4 ((12)): [PMID:31145699]
17. P G Wolff-Kormann,B A Kormann,K G Riedel,C Keller,K D Miliczek,E Zrenner. (1991-01-01) [Ocular side effects of beta-pyridylcarbinol].. Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 88 ((6)): (857-860). [PMID:1794821]
18. J B Moynihan. (1990-04-01) Acetazolamide-resistant carbonic anhydrase activity with expansion of the vascular bed in tonic skeletal muscle of rats.. Biochemical Society transactions, 18 ((2)): (268-269). [PMID:2116335]
19. N Zöllner. (1989-01-01) Effects of nicotinic acid, nicotinamide, and pyridylcarbinol in pharmacological dosages on lipid metabolism in humans.. International journal for vitamin and nutrition research. Supplement = Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Supplement, 30 (114-119). [PMID:2529321]
20. E Tadmor,P Poitou,I Gedalia. (1989-11-01) In vitro acid decalcification of human surface enamel pretreated with toothpaste slurries.. Journal of oral rehabilitation, 16 ((6)): (613-616). [PMID:2600715]
21. T Fazekas,L Szekeres. (1989-01-01) Effects of the lipolysis inhibiting agent beta-pyridylcarbinol (Ronicol) in acute myocardial ischaemia.. Acta physiologica Hungarica, 74 ((2)): (169-174). [PMID:2603732]
22. H Arola. (1988-09-01) The strip test for hypolactasia also works without ethanol.. Scandinavian journal of gastroenterology, 23 ((7)): (851-855). [PMID:3227302]
23. J P Dubiel,E Cibor,K Bieron,A Zmuda,E Kostka-Trabka. (1988-01-01) [Effect of beta-pyridylcarbinol on pulmonary arterial pressure and various indicators of the blood coagulation system in patients with secondary pulmonary hypertension].. Kardiologia polska, 31 ((10)): (626-632). [PMID:3253452]
24. M Meylan,C Henny,E Temler,E Jéquier,J P Felber. (1987-03-01) Metabolic factors in the insulin resistance in human obesity.. Metabolism: clinical and experimental, 36 ((3)): (256-261). [PMID:3547014]
25. Y Pocker,S C De Roy. (1987-01-01) The active site of liver alcohol dehydrogenase mechanistic inferences from the binding and turnover of 2-, 3-, and 4-pyridylcarbinols.. Progress in clinical and biological research, 232 (179-187). [PMID:3615419]
26. Rastislav Sípos,Terézia Szabó-Plánka,Antal Rockenbauer,Nóra Veronika Nagy,Jozef Sima,Milan Melník,István Nagypál. (2008-09-11) Equilibria of 3-pyridylmethanol with copper(II). A comparative electron spin resonance study by the decomposition of spectra in liquid and frozen solutions.. The journal of physical chemistry. A, 112 ((41)): (10280-10286). [PMID:18781728]

溶液计算器

摩尔浓度计算器

计算溶液所需的质量、体积或浓度。

质量

浓度

体积

分子量

g/mol

稀释计算器

计算配制储备溶液所需的稀释度。

浓度1（C1）

体积 1 (V1)

浓度 2 (C2)

体积 2 (V2)

复溶计算器

复溶计算器允许您快速计算试剂的体积，以复溶小瓶。只需输入试剂的质量和目标浓度，计算器将确定其余部分。

体积（添加到小瓶中）

质量（小瓶）

所需的复溶浓度